The medtech company Sensodetect reports a loss in the fourth quarter of 2025. No comparative figures are provided as the group was formed in the second quarter of 2025. Net sales amounted to SEK 1.1 million.The operating result was SEK -2.7 million. The result before and after tax was SEK -3.0 million. Earnings per share amounted to SEK -0.007. Cash flow from operating activities amounted to SEK -2.1 million. Cash and cash equivalents amounted to SEK 2.0 million at year-end.- The fourth quarter marks the conclusion of a year in which Sensodetect has focused on establishing structures, work processes, and collaborations that are considered important for the company’s continued development. Ahead of 2026, the focus is on continued work within regulatory processes, technical completion, and the management of commercial opportunities in cooperation with strategic partners, comments CEO PA Hedin in the year-end report. Sensodetect, MSEKQ4-2025Net sales1.1Operating result-2.7Result before tax-3.0Net result-3.0Earnings per share, SEK-0.007Cash flow from operating activities-2.1Cash and cash equivalents2.0